Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

Mousumi Bose, Blanca Oliván, Julio Teixeira, F. Xavier Pi-Sunyer, Blandine Laferrère

Research output: Contribution to journalReview article

113 Citations (Scopus)

Abstract

Gastric bypass surgery (GBP), in addition to weight loss, results in dramatic remission of type 2 diabetes (T2DM). The mechanisms by which this remission occurs are unclear. Besides weight loss and caloric restriction, the changes in gut hormones that occur after GBP are increasingly gaining recognition as key players in glucose control. Incretins are gut peptides that stimulate insulin secretion postprandially; the levels of these hormones, particularly glucagon-like peptide-1, increase after GBP in response to nutrient stimulation. Whether these changes are causal to changes in glucose homeostasis remain to be determined. The purpose of this review is to assess the evidence on incretin changes and T2DM remission after GBP, and the possible mechanisms by which these changes occur. Our goals are to provide a thorough update on this field of research so that recommendations for future research and criteria for bariatric surgery can be evaluated.

Original languageEnglish
Pages (from-to)217-229
Number of pages13
JournalObesity Surgery
Volume19
Issue number2
DOIs
StatePublished - 1 Feb 2009

Fingerprint

Incretins
Gastric Bypass
Type 2 Diabetes Mellitus
Weight Loss
Hormones
Glucose
Caloric Restriction
Glucagon-Like Peptide 1
Bariatric Surgery
Homeostasis
Insulin
Food
Peptides
Research

Keywords

  • Diabetes
  • GIP
  • GLP-1
  • Gastric bypass
  • Incretin
  • Insulin
  • Weight loss

Cite this

Bose, Mousumi ; Oliván, Blanca ; Teixeira, Julio ; Pi-Sunyer, F. Xavier ; Laferrère, Blandine. / Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery : What are the evidence?. In: Obesity Surgery. 2009 ; Vol. 19, No. 2. pp. 217-229.
@article{231ef853f36143dc94a396302482be83,
title = "Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?",
abstract = "Gastric bypass surgery (GBP), in addition to weight loss, results in dramatic remission of type 2 diabetes (T2DM). The mechanisms by which this remission occurs are unclear. Besides weight loss and caloric restriction, the changes in gut hormones that occur after GBP are increasingly gaining recognition as key players in glucose control. Incretins are gut peptides that stimulate insulin secretion postprandially; the levels of these hormones, particularly glucagon-like peptide-1, increase after GBP in response to nutrient stimulation. Whether these changes are causal to changes in glucose homeostasis remain to be determined. The purpose of this review is to assess the evidence on incretin changes and T2DM remission after GBP, and the possible mechanisms by which these changes occur. Our goals are to provide a thorough update on this field of research so that recommendations for future research and criteria for bariatric surgery can be evaluated.",
keywords = "Diabetes, GIP, GLP-1, Gastric bypass, Incretin, Insulin, Weight loss",
author = "Mousumi Bose and Blanca Oliv{\'a}n and Julio Teixeira and Pi-Sunyer, {F. Xavier} and Blandine Laferr{\`e}re",
year = "2009",
month = "2",
day = "1",
doi = "10.1007/s11695-008-9696-3",
language = "English",
volume = "19",
pages = "217--229",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York",
number = "2",

}

Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery : What are the evidence? / Bose, Mousumi; Oliván, Blanca; Teixeira, Julio; Pi-Sunyer, F. Xavier; Laferrère, Blandine.

In: Obesity Surgery, Vol. 19, No. 2, 01.02.2009, p. 217-229.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery

T2 - What are the evidence?

AU - Bose, Mousumi

AU - Oliván, Blanca

AU - Teixeira, Julio

AU - Pi-Sunyer, F. Xavier

AU - Laferrère, Blandine

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Gastric bypass surgery (GBP), in addition to weight loss, results in dramatic remission of type 2 diabetes (T2DM). The mechanisms by which this remission occurs are unclear. Besides weight loss and caloric restriction, the changes in gut hormones that occur after GBP are increasingly gaining recognition as key players in glucose control. Incretins are gut peptides that stimulate insulin secretion postprandially; the levels of these hormones, particularly glucagon-like peptide-1, increase after GBP in response to nutrient stimulation. Whether these changes are causal to changes in glucose homeostasis remain to be determined. The purpose of this review is to assess the evidence on incretin changes and T2DM remission after GBP, and the possible mechanisms by which these changes occur. Our goals are to provide a thorough update on this field of research so that recommendations for future research and criteria for bariatric surgery can be evaluated.

AB - Gastric bypass surgery (GBP), in addition to weight loss, results in dramatic remission of type 2 diabetes (T2DM). The mechanisms by which this remission occurs are unclear. Besides weight loss and caloric restriction, the changes in gut hormones that occur after GBP are increasingly gaining recognition as key players in glucose control. Incretins are gut peptides that stimulate insulin secretion postprandially; the levels of these hormones, particularly glucagon-like peptide-1, increase after GBP in response to nutrient stimulation. Whether these changes are causal to changes in glucose homeostasis remain to be determined. The purpose of this review is to assess the evidence on incretin changes and T2DM remission after GBP, and the possible mechanisms by which these changes occur. Our goals are to provide a thorough update on this field of research so that recommendations for future research and criteria for bariatric surgery can be evaluated.

KW - Diabetes

KW - GIP

KW - GLP-1

KW - Gastric bypass

KW - Incretin

KW - Insulin

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=58649086097&partnerID=8YFLogxK

U2 - 10.1007/s11695-008-9696-3

DO - 10.1007/s11695-008-9696-3

M3 - Review article

C2 - 18820978

AN - SCOPUS:58649086097

VL - 19

SP - 217

EP - 229

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 2

ER -